Table 2 Socio-demographic and reported clinical characteristics of 167 HIV-positive individuals who were serum T.pallidum seropositive compared to 1581 T.pallidum seronegative Participants
Variable | TPHA Positive | X2 | P-Value | |
|---|---|---|---|---|
YES N (%) | NO N (%) | |||
Gender | ||||
Male | 46 (27.5) | 450(28.5) | 0.063 | 0.802 |
Female | 121(72.5) | 1131(71.5) | ||
Age | ||||
18–39 | 58(34.7) | 671(42.4) | 6.349 | 0.044 |
40–64 | 100(59.9) | 866(54.8) | ||
65–84 | 9(5.4) | 44(2.8) | ||
Marital status | ||||
Single | 38(22.8) | 505(31.9) | 15.73 | < 0.001 |
Married(monogamy) | 94(56.3) | 846(53.3) | ||
Widow | 32(19.2) | 226(14.3) | ||
Polygamy | 3(1.8) | 4(0.25) | ||
Education | ||||
Illiterate | 29(17.4) | 97(6.1) | 34.53 | < 0.001 |
Primary | 112(67.1) | 1058(66.9) | ||
Secondary | 21(12.5) | 352(22.3) | ||
College | 3(1.8) | 57(3.6) | ||
University | 2(1.2) | 17(1.1) | ||
Residence | ||||
Mwanza city | 148(88.6) | 1404(89) | 0.005 | 0.944 |
Outside Mwanza city | 19(11.4) | 177(11) | ||
Occupation | ||||
Vendor | 104(62.3) | 1010(63.9) | 19.28 | < 0.001 |
Peasant | 44(26.4) | 294(18.6) | ||
Fisherman | 2(1.2) | 8(0.5) | ||
Employed | 6(4.0) | 205(13.0) | ||
House wife | 11(6.6) | 64(4.1) | ||
Reports previous history of syphilis | ||||
No | 149(89.2) | 1546(97.8) | 37.68 | < 0.001 |
Yes | 18(10.8) | 35(2.2) | ||
Reported previous treated syphilis | ||||
No | 6(33.3) | 11(0.7) | 0.02 | 0.888 |
Yes | 12(66.7) | 24(1.5) | ||
Reports penicillin injection | ||||
One | 2(16.6) | 2(8.30) | 0.563 | 0.453 |
Three | 10(83.3) | 22(91.7) | ||
History of genital lesion | ||||
No | 153(91.6) | 1545(97.7) | 20.27 | < 0.001 |
Yes | 14(8.4) | 36(2.3) | ||
Number of lesion | ||||
One | 10(71.4) | 5(13.9) | 15.89 | < 0.001 |
Two or more | 4(28.6) | 31(89.1) | ||
Duration of lesion | ||||
Less than a year | 9(64.3) | 20(55.6) | 0.536 | 0.911 |
Two to three year | 3(21.5) | 8(22.2) | ||
4 to six year | 1(7.1) | 3(8.3) | ||
More than six year | 1(7.1) | 5(13.9) | ||
Rashes on palms and soles | ||||
No | 164(98.2) | 1576(99.6) | 7.264 | 0.007 |
Yes | 3(1.8) | 5(0.3) | ||
Treatment for rashes | ||||
No | 3(100.0) | 0(0) | 8 | 0.005 |
Yes | 0(0.0) | 5(100) | ||
ART use | ||||
No | 1(0.6) | 0(0) | 9.473 | 0.002 |
Yes | 166(99.4) | 1681(100) | ||
Duration of ART use | ||||
Less 6 month | 3(1.8) | 0 | 1400 | < 0.001 |
6 month to 2 years | 25(15.0) | 0 | ||
Above 2 yrs | 111(66.5) | 0 | ||
Missing | 28(16.8) | 1681 | ||
Viral load(copies/ml) | ||||
Less than 50 | 130(77.8) | 1203(79.1) | 1.424 | 0.7 |
50–999 | 7(4.2) | 71(4.5) | ||
1000 or more | 10(6.0) | 74(4.7) | ||
Missed viral load | 20(12.0) | 233(14.7) | ||
CD4 cell/uL | ||||
Less than 350 | 35(21.0) | 271(17.1) | 1.638 | 0.441 |
350 and above | 94(56.3) | 914(57.8) | ||
Missing | 38(22.7) | 396(25.15) | ||
CSF WBC/UL | ||||
Less than or equal 5 | 4(100.0) | |||
Greater 5 | 0(0.0) | |||
CSF Treponema antibody | ||||
Negative | 3(75.0) | |||
Positive | 1(25.0) | |||